Bioinformatics Study of Flavonoids From Genus Erythrina As Ace2 inhibitor Candidates For Covid-19 Treatment

References

• World Health Organization. COVID-19 epidemiological update – 19 January 2024. Available from: https://www.who.int/publications/m/item/covid-19-epidemiological-update---19-january-2024. Accessed May 10, 2024.
   Google Scholar
• Rabie AM. Potent Inhibitory Activities of the Adenosine Analogue Cordycepin on SARS-CoV-2 Replication. ACS Omega. 2022;7(3):2960–2969. doi:10.1021/acsomega.1c05998
   PubMed Web of Science ®Google Scholar
• Li Q, Lai L. Prediction of potential drug targets based on simple sequence properties. BMC Bioinf. 2007;8(1). doi:10.1186/1471-2105-8-353
   Google Scholar
• Rabie AM. Future of the current anticoronaviral agents: a viewpoint on the validation for the next COVIDs and pandemics. Biocell. 2023;47(10):2133–2139. doi:10.32604/biocell.2023.030057
   Web of Science ®Google Scholar
• Rabie AM, Abdalla M. Forodesine and Riboprine Exhibit Strong Anti-SARS-CoV-2 Repurposing Potential: in Silico and In Vitro Studies. ACS Bio and Med Chem Au. 2022;2(6):565–585. doi:10.1021/acsbiomedchemau.2c00039
   PubMedGoogle Scholar
• Jia H, Neptune E, Cui H. Targeting ACE2 for COVID-19 Therapy: opportunities and challenges. Am J Respir Cell Mol Biol. 2021;64(4):416–425. doi:10.1165/rcmb.2020-0322PS
   PubMed Web of Science ®Google Scholar
• Hochuli JE, Jain S, Melo-Filho C, et al. Allosteric Binders of ACE2 Are Promising Anti-SARS-CoV-2 Agents. ACS Pharmacol Transl Sci. 2022;5(7):468–478. doi:10.1021/acsptsci.2c00049
   PubMedGoogle Scholar
• Goulding LV, Yang J, Jiang Z, et al. Thapsigargin at non-cytotoxic levels induces a potent host antiviral response that blocks influenza a virus replication. Viruses. 2020;12(10):1093. doi:10.3390/v12101093
   PubMed Web of Science ®Google Scholar
• Tutunchi H, Naeini F, Ostadrahimi A, Hosseinzadeh-Attar MJ. Naringenin, a flavanone with antiviral and anti-inflammatory effects: a promising treatment strategy against COVID −19. Phytother Res. 2020;34(12):3137–3147. doi:10.1002/ptr.6781
   PubMed Web of Science ®Google Scholar
• Loizzo MR, Said A, Tundis R, et al. Inhibition of angiotensin converting enzyme (ACE) by flavonoids isolated from Ailanthus excelsa (Roxb) (Simaroubaceae). Phytother Res. 2007;21(1):32–36. doi:10.1002/ptr.2008
   PubMed Web of Science ®Google Scholar
• Fahmy NM, Al-Sayed E, El-Shazly M, Singab AN. Comprehensive review on flavonoids biological activities of Erythrina plant species. Ind Crops Prod. 2018;123:500–538. doi:10.1016/j.indcrop.2018.06.028
   Web of Science ®Google Scholar
• Son NT, Elshamy AI. Flavonoids and other Non-alkaloidal Constituents of Genus Erythrina: phytochemical Review. Comb Chem High Throughput Screen. 2021;24(1):20–58. doi:10.2174/1386207323666200609141517
   PubMed Web of Science ®Google Scholar
• Kone WM, Solange KNE, Dosso M. Assessing sub-saharian Erythrina for efficacy: traditional uses, biological activities and phytochemistry. Pak J Biological Sci. 2011;14(10):560–571. doi:10.3923/pjbs.2011.560.571
   PubMedGoogle Scholar
• Shen C, Ding J, Wang Z, Cao D, Ding X, Hou T. From machine learning to deep learning: advances in scoring functions for protein–ligand docking. Wiley Interdiscip Rev Comput Mol Sci. 2020;10(1). doi:10.1002/wcms.1429
   Web of Science ®Google Scholar
• Miles JA, Ross BP. Recent Advances in Virtual Screening for Cholinesterase Inhibitors. ACS Chem Neurosci. 2021;12(1):30–41. doi:10.1021/acschemneuro.0c00627
   PubMed Web of Science ®Google Scholar
• Rajendran M, Roy S, Ravichandran K, et al. In silico screening and molecular dynamics of phytochemicals from Indian cuisine against SARS-CoV-2 M Pro. J Biomol Struct Dyn. 2022;40(7):3155–3169. doi:10.1080/07391102.2020.1845980
   PubMed Web of Science ®Google Scholar
• Gimeno A, Ojeda-Montes MJ, Tomás-Hernández S, et al. The light and dark sides of virtual screening: what is there to know? Int J Mol Sci. 2019;20(6):1375. doi:10.3390/ijms20061375
   PubMed Web of Science ®Google Scholar
• Nishinarizki V, Hardianto A, Gaffar S, Muchtaridi M, Herlina T. Virtual screening campaigns and ADMET evaluation to unlock the potency of flavonoids from Erythrina as 3CLpro SARS-COV-2 inhibitors. J Appl Pharm Sci. 2023;13(2). doi:10.7324/JAPS.2023.130209
   Google Scholar
• Pires DEV, Blundell TL, Ascher DB. pkCSM: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures. J Med Chem. 2015;58(9):4066–4072. doi:10.1021/acs.jmedchem.5b00104
   PubMed Web of Science ®Google Scholar
• Lan J, Ge J, Yu J, et al. Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor. Nature. 2020;581(7807):215–220. doi:10.1038/s41586-020-2180-5
   PubMed Web of Science ®Google Scholar
• Goodsell DS, Sanner MF, Olson AJ, Forli S. The AutoDock suite at 30. Protein Sci. 2021;30(1):31–43. doi:10.1002/pro.3934
   PubMedGoogle Scholar
• Hardianto A, Yusuf M, Hidayat IW, Ishmayana S, Soedjanaatmadja UMS. Exploring the Potency of Nigella sativa Seed in Inhibiting SARS-CoV-2 Main Protease Using Molecular Docking and Molecular Dynamics Simulations. Indonesian J Chem. 2021;21(5):1252. doi:10.22146/IJC.65951
   Web of Science ®Google Scholar
• Roe DR, Cheatham TE. PTRAJ and CPPTRAJ: software for processing and analysis of molecular dynamics trajectory data. J Chem Theory Comput. 2013;9(7):3084–3095. doi:10.1021/ct400341p
   PubMed Web of Science ®Google Scholar
• Daina A, Michielin O, Zoete V. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep. 2017;7(1). doi:10.1038/srep42717
   PubMedGoogle Scholar
• Okocha RC, Olatoye IO, Adedeji OB. Food safety impacts of antimicrobial use and their residues in aquaculture. Public Health Rev. 2018;39(1). doi:10.1186/s40985-018-0099-2
   PubMedGoogle Scholar
• Garrido A, Lepailleur A, Mignani SM, Dallemagne P, Rochais C. hERG toxicity assessment: useful guidelines for drug design. Eur J Med Chem. 2020;195. doi:10.1016/j.ejmech.2020.112290
   Web of Science ®Google Scholar
• Meunier L, Larrey D. Drug-induced liver injury: biomarkers, requirements, candidates, and validation. Front Pharmacol. 2019;10. doi:10.3389/fphar.2019.01482
   PubMed Web of Science ®Google Scholar
• Shultz MD. Two Decades under the Influence of the Rule of Five and the Changing Properties of Approved Oral Drugs. J Med Chem. 2019;62(4):1701–1714. doi:10.1021/acs.jmedchem.8b00686
   PubMed Web of Science ®Google Scholar
• James JP, Ail PD, Crasta L, Kamath RS, Shura MH, S TJ. In Silico ADMET and Molecular Interaction Profiles of Phytochemicals from Medicinal Plants in Dakshina Kannada. J Health Allied Sci NU. 2023. doi:10.1055/s-0043-1770057
   Google Scholar
• Matondo A, Dendera W, Isamura BK, et al. In silico Drug Repurposing of Anticancer Drug 5-FU and Analogues Against SARS-CoV-2 Main Protease: molecular Docking, Molecular Dynamics Simulation, Pharmacokinetics and Chemical Reactivity Studies. <![CDATA[Advances and Applications in Bioinformatics and Chemistry]]>. 2022;15:59–77. doi:10.2147/AABC.S366111
   PubMedGoogle Scholar
• Rabie AM, Eltayb WA. Potent Dual Polymerase/Exonuclease Inhibitory Activities of Antioxidant Aminothiadiazoles Against the COVID-19 Omicron Virus: a Promising In Silico/In Vitro Repositioning Research Study. Mol Biotechnol. 2023;66(4):592–611. doi:10.1007/s12033-022-00551-8
   PubMedGoogle Scholar
• Chamata Y, Jackson KG, Watson KA, Jauregi P. Whey-derived peptides at the heart of the covid-19 pandemic. Int J Mol Sci. 2021;22(21):11662. doi:10.3390/ijms222111662
   PubMed Web of Science ®Google Scholar
• Sui H, Yu Q, Zhi Y, Geng G, Liu H, Xu H. Effects of apigenin on the expression of angiotensin-converting enzyme 2 in kidney in spontaneously hypertensive rats. Wei Sheng Yan Jiu. 2010;39(6):693–6, 700.
   PubMedGoogle Scholar
• Hettihewa SK, Hemar Y, Vasantha Rupasinghe HP. Flavonoid-rich extract of Actinidia macrosperma (a wild kiwifruit) inhibits angiotensin-converting enzyme in vitro. Foods. 2018;7(9):146. doi:10.3390/foods7090146
   PubMed Web of Science ®Google Scholar
• Guerrero L, Castillo J, Quiñones M, et al. Inhibition of Angiotensin-Converting Enzyme Activity by Flavonoids: structure-Activity Relationship Studies. PLoS One. 2012;7(11):e49493. doi:10.1371/journal.pone.0049493
   PubMed Web of Science ®Google Scholar
• Son NT, Elshamy AI. Flavonoids and other Non-alkaloidal Constituents of Genus Erythrina: phytochemical Review. Comb Chem High Throughput Screen. 2020;24(1):20–58. doi:10.2174/1386207323666200609141517
   Web of Science ®Google Scholar
• Han DP, Penn-Nicholson A, Cho MW. Identification of critical determinants on ACE2 for SARS-CoV entry and development of a potent entry inhibitor. Virology. 2006;350(1):15–25. doi:10.1016/j.virol.2006.01.029
   PubMed Web of Science ®Google Scholar
• Kashyap P, Thakur M, Singh N, et al. In Silico Evaluation of Natural Flavonoids as a Potential Inhibitor of Coronavirus Disease. Molecules. 2022;27(19):6374. doi:10.3390/molecules27196374
   PubMed Web of Science ®Google Scholar
• Lee MY, Kumar RA, Sukumaran SM, Hogg MG, Clark DS, Dordick JS. Three-dimensional cellular microarray for high-throughput toxicology assays. Proc Natl Acad Sci U S A. 2008;105(1):59–63. doi:10.1073/pnas.0708756105
   PubMed Web of Science ®Google Scholar
• Mansoor A, Mahabadi N. Volume of Distribution. StatPearls Publishing; 2022.
   Google Scholar
• Heo JK, Kim HJ, Lee GH, et al. Simultaneous determination of five cytochrome P450 probe substrates and their metabolites and organic anion transporting polypeptide probe substrate in human plasma using liquid chromatography-tandem mass spectrometry. Pharmaceutics. 2018;10(3):79. doi:10.3390/pharmaceutics10030079
   PubMed Web of Science ®Google Scholar
• Tapaninen T, Olkkola AM, Tornio A, et al. Itraconazole Increases Ibrutinib Exposure 10-Fold and Reduces Interindividual Variation—A Potentially Beneficial Drug-Drug Interaction. Clin Transl Sci. 2020;13(2):345–351. doi:10.1111/cts.12716
   PubMed Web of Science ®Google Scholar